Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Explore linked clinical trials.5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully | HIV-1-infection | Recruiting | Phase 2 | 2025-06-11 | NCT06774872 | |
| Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women | Vulnerable Population | Recruiting | Not applicable | 2025-05-30 | NCT06996938 | |
| Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France | HIV I Infection | Recruiting | Not stated | 2025-05-22 | NCT06799338 | |
| Evolution of the Clinical, Immuno-virological and Aging Trajectory of Patients Living With HIV | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2025-01-10 | NCT06258122 | |
| HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2025-01-10 | NCT04513626 |